Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Swern Oxidation and Lewis Acid Catalyzed C H Insertion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303006A reveals a safer Swern oxidation and C-H insertion route for amlodipine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain stability.